Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence
Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm (www.Debiopharm.com), announced today […]
BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today […]
Neurolens Raises $67 Million from MVM Partners, Falcon Vision/KKR, Marshall Wace & Existing Investors
Neurolens, a company commercializing innovative solutions to optimize vision, today announced completion of a $67 million financing. […]
Compugen Announces Appointment of Alberto Sessa as Chief Financial Officer
Compugen Ltd. ( Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced […]
Redbud Raises $10M in Series A Round as CRO Focusing on Science-driven Clinical Development
Redbud Medicine, the Delaware-headquartered contract research organization (CRO) announced on Monday following the completion of a series […]
Brain Navi Biotechnology Announced Partnership With Distributor, Medtreq Medical Equipment, to Enter the Middle East and Egypt With NaoTrac Neurosurgical Robot
Brain Navi, the leading surgical robot manufacture in Taiwan, announced a strategic partnership with distributor, Medtreq […]
BIOTRONIK Announces Collaboration with AliveCor As First In A Series of Strategic Partnerships to Disrupt Cardiac Digital Health With AI-Enabled Solutions
BIOTRONIK announced today its partnership with AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and […]
Cue Health Appoints David Tsay, MD, PhD, as Chief Medical Officer
Cue Health Inc. (“Cue”) ( Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed David […]
ArisGlobal Accelerates Growth, Announces Executive Evolution
ArisGlobal, the leading provider of life sciences software that automates core drug development functions with […]
Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials
Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more